(Q38392009)

2 September 2017

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies (English)

1 reference

2 September 2017

1

Alan W Partin

1 reference

2 September 2017

15

Jonathan I Epstein

1 reference

2 September 2017

Leander Van Neste

2

1 reference

2 September 2017

Eric A Klein

3

1 reference

2 September 2017

Leonard S Marks

4

1 reference

2 September 2017

Jason R Gee

5

1 reference

2 September 2017

Dean A Troyer

6

1 reference

2 September 2017

Kimberly Rieger-Christ

7

1 reference

2 September 2017

J Stephen Jones

8

1 reference

2 September 2017

Cristina Magi-Galluzzi

9

1 reference

2 September 2017

Leslie A Mangold

10

1 reference

2 September 2017

Bruce J Trock

11

1 reference

2 September 2017

Raymond S Lance

12

1 reference

2 September 2017

Joseph W Bigley

13

1 reference

2 September 2017

Wim Van Criekinge

14

1 reference

2 September 2017

language of work or name

English

0 references

publication date

18 April 2014

1 reference

2 September 2017

1 reference

2 September 2017

192

1 reference

2 September 2017

4

1 reference

2 September 2017

1081-1087

1 reference

Epigenetic susceptibility factors for prostate cancer with aging.

2 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

6 September 2017

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

The epigenetic promise for prostate cancer diagnosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Complications after prostate biopsy: data from SEER-Medicare

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

KEGG for representation and analysis of molecular networks involving diseases and drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Screening and prostate-cancer mortality in a randomized European study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

CpG island methylator phenotype in colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Epigenetic regulation of Wnt signaling pathway in urological cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Sample size for positive and negative predictive value in diagnostic research using case-control designs

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Using the epigenetic field defect to detect prostate cancer in biopsy negative patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337855

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24747657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24747657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

To biopsy or not to biopsy--thou shall think twice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24747657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JURO.2014.04.013

1 reference

2 September 2017

1 reference

2 September 2017

PubMed publication ID

24747657

1 reference